JS Link

127120 · KOSDAQ · ₩127120 · 제이에스링크

₩19,200▲ ₩570 (3.06%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −0.36%
Market cap
₩718B
Enterprise value
₩698B
P/E
—
P/B
6.9×
Dividend yield
0.0%
ROE
−5.1%
Net margin
−23.3%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−61.5% from the high

₩13,860Today: ₩18,600 – ₩20,500₩49,900

Returns

  • 1W+12.5%
  • 1M−35.4%
  • 3M−30.8%
  • 6M−52.9%
  • YTD+7.6%
  • 1Y−0.4%
Volume today
177,964
0.9× the 20-day average
Traded today
₩3.4B
Listed shares
37,421,032
EPS (12 months)
−₩142
Earnings yield −0.7%

Signals

39Quiet
  • BuzzQuietBuzz 39 of 100 (50 is a normal day for this stock).
  • MomentumWeak-40.4% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Leveraged ETF flows

Estimated leveraged-ETF rebalance on Oct 29: sell ₩205M at the close (4.1% of 20-day average trading value)

Sep 30Last 20 trading days (% of average trading value)Oct 29

On its 31 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 21.0% of trading value and pointed the same way 22 of 31 times.

  • 2× KODEX KOSDAQ150 Leverage −₩143M
  • -1× KODEX KOSDAQ150 Futures Inverse −₩35M
  • 2× TIGER KOSDAQ150 Leverage −₩18M
  • 2× RISE KOSDAQ150 Futures Leverage −₩6.7M
  • -1× TIGER KOSDAQ150 Futures Inverse −₩1.2M

Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.

Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.

Estimate based on ETF size and daily moves; actual trades may differ.

ETFs holding this

All ETFs →

Held by 11 funds.

Estimated from the funds' index or underlying stock.

JS Link stock overview

JS Link (제이에스링크, KRX: 127120) is listed on KOSDAQ, in the Biotech & Pharma sector. The company operates in genome analysis and molecular diagnostics, offering genetic testing and sequencing services to healthcare providers, pharmaceutical companies, research institutions, and direct-to-consumer customers. Its shares closed at ₩19,200 on Oct 29, 2026, up 3.06% on the day, giving it a market value of ₩718B.

Key facts

Market cap
₩718B
Sector
Biotech & Pharma
Latest price change
+3.06%
As of
Oct 29, 2026
Main business
The company operates in genome analysis and molecular diagnostics, offering genetic testing and sequencing services to healthcare providers, pharmaceutical companies, research institutions, and direct-to-consumer customers.

Quick answers about JS Link

What does JS Link do?
The company operates in genome analysis and molecular diagnostics, offering genetic testing and sequencing services to healthcare providers, pharmaceutical companies, research institutions, and direct-to-consumer customers. Its business centers on next-generation sequencing, biobanking, and personal identification, and it has also entered the permanent magnet manufacturing business, with its products used in electric vehicles, robots, and other industries.
What is the market cap of JS Link?
The market capitalisation of JS Link was ₩718B at the close on Oct 29, 2026.
Who are the largest shareholders of JS Link?
According to the latest official filings, the largest reported holders are Jusung C&A (28.46%, as of Oct 16, 2026); National Pension Service (5.05%, as of Jul 1, 2026); Orbitech (4.33%, as of Apr 2, 2025).
When is the next earnings report from JS Link?
Korean companies rarely announce results dates in advance. Based on when JS Link filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Does the National Pension Service own JS Link?
Yes. The National Pension Service held 5.05% of JS Link shares as of Jul 1, 2026.

Company profile

The company operates in genome analysis and molecular diagnostics, offering genetic testing and sequencing services to healthcare providers, pharmaceutical companies, research institutions, and direct-to-consumer customers. Its business centers on next-generation sequencing, biobanking, and personal identification, and it has also entered the permanent magnet manufacturing business, with its products used in electric vehicles, robots, and other industries.

Written by AI from the company's latest annual report.

Korean name
제이에스링크
CEO
박진수
Founded
Mar 2000
Listed
Dec 2011
Listed shares
37,421,032
Fiscal year ends
Month 12

Similar companies

Recent news

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: JS Link / 제이에스링크 / 127120 / KRX:127120

Source: KRX statistical information